Trial Profile
Decreased Carriage and Genetic Shifts in the Streptococcus pneumoniae Population After Changing the 7-Valent to the 13-Valent Pneumococcal Vaccine in Norway.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 08 Dec 2015 New trial record